By mid-day on Tuesday, people from China, Texas, Japan and New Mexico had met with Justin Briggs from Oklahoma City’s Accele BioPharma Inc., at the 2015 international convention of the Biotechnology Industry Organization .
News
There is a pioneering quality to Oklahoma City-based Altheus Therapeutics and the milestones the company has achieved in advancing a new drug therapy for a painful condition known as inflammatory bowel disease.
Justin Briggs is raising money for a technology startup company. But he has just one condition: He wants to stay in Oklahoma.
